Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.05 AUD | -0.50% | -2.99% | -16.25% |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
Feb. 29 | Knight Therapeutics Announces Launch of Minjuvi in Brazil | MT |
Sales 2024 * | 993M 656M | Sales 2025 * | 1.05B 691M | Capitalization | 1.42B 936M |
---|---|---|---|---|---|
Net income 2024 * | 101M 66.74M | Net income 2025 * | 117M 77.31M | EV / Sales 2024 * | 1.8 x |
Net Debt 2024 * | 368M 243M | Net Debt 2025 * | 327M 216M | EV / Sales 2025 * | 1.67 x |
P/E ratio 2024 * |
14.1
x | P/E ratio 2025 * |
12.2
x | Employees | 1,996 |
Yield 2024 * |
4.17% | Yield 2025 * |
4.81% | Free-Float | 95.34% |
Latest transcript on GUD Holdings Limited
1 day | -0.50% | ||
1 week | -2.99% | ||
Current month | -2.52% | ||
1 month | -10.75% | ||
3 months | -17.49% | ||
6 months | -9.30% | ||
Current year | -16.25% |
Managers | Title | Age | Since |
---|---|---|---|
Graeme Whickman
CEO | Chief Executive Officer | - | 18-09-30 |
Director of Finance/CFO | - | 11-12-31 | |
Anne Mustow
IRC | Investor Relations Contact | - | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Pollaers
BRD | Director/Board Member | 62 | 21-06-22 |
Graeme Billings
CHM | Chairman | 68 | 11-12-19 |
David Robinson
BRD | Director/Board Member | 75 | 11-12-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - | |
0.00% | 7 M€ | +3.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 10.05 | -0.50% | 394,537 |
24-05-02 | 10.1 | -0.98% | 423,516 |
24-05-01 | 10.2 | -1.07% | 364,003 |
24-04-30 | 10.31 | -2.83% | 599,773 |
24-04-29 | 10.61 | +2.41% | 620,489 |
Delayed Quote Australian S.E., May 03, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.25% | 936M | |
+26.07% | 51.05B | |
-9.91% | 22.04B | |
+25.92% | 20.17B | |
+33.27% | 17.52B | |
-4.64% | 15.13B | |
-18.39% | 13.41B | |
-19.97% | 13.26B | |
+33.81% | 12.25B | |
+28.63% | 10.66B |
- Stock Market
- Equities
- GUD Stock